Altogether, these observations suggest that orexin may be useful to better understand and discover biomarkers of metabolic vulnerability representing a novel target for the treatment of diet-related metabolic disorders, such as obesity/anorexia. The gene discussed is HCRT; the disease is metabolic disease.